• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, INC. VIRTUO A UNIT; VIRTUO® A UNIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, INC. VIRTUO A UNIT; VIRTUO® A UNIT Back to Search Results
Model Number 411660
Device Problem Communication or Transmission Problem (2896)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in (b)(6) notified biomérieux of a premature bottle discharge in association with their bact/alert®-virtuo® system (ref.4703336), stating the bottle was discharged from the instrument after five (5) days of incubation.The customer stated the bottle was set to incubate for fourteen (14) days for a red blood cell sterility test from a cytapheresis sample.There was no error message or notification associated with the premature bottle discharge.Subculture of the bottle was not performed.There is no indication or report from the laboratory that the premature bottle discharge led to any adverse event related to any patient's state of health.Biomérieux has initiated an internal investigation.
 
Manufacturer Narrative
This report was initially submitted following notification from a customer in france regarding a premature bottle discharge in association with their bact/alert®-virtuo® system (ref.(b)(4)), stating the bottle was discharged from the instrument after five (5) days of incubation.The bottle was set to incubate for fourteen (14) days.An internal investigation was conducted analyzing the instruments log files.The review concluded the root cause of the issue was a timing condition.Once the bottle data is scanned and identified by the instrument, myla immediately downloads the bottle message that contains the maximum test time (mtt) change.Ample amount of time was not allowed for the master control board (mcb) to correctly interpret the mtt change.This anomaly has been addressed and not present in the upcoming virtuo® 3.0 version.Field correction action (fca) 4532 was issued informing customers of the identified maximum test time anomaly associated with the bact/alert®virtuo® system release 2.0.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIRTUO A UNIT
Type of Device
VIRTUO® A UNIT
Manufacturer (Section D)
BIOMERIEUX, INC.
595 anglum road
hazelwood MO 63042
MDR Report Key10080540
MDR Text Key203145971
Report Number1950204-2020-00132
Device Sequence Number1
Product Code MDB
UDI-Device Identifier03573026369767
UDI-Public03573026369767
Combination Product (y/n)N
PMA/PMN Number
K161816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 08/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number411660
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/11/2020
Initial Date FDA Received05/21/2020
Supplement Dates Manufacturer Received07/09/2020
Supplement Dates FDA Received08/05/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-